Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
Novartis
Novartis
Kivu Bioscience Inc.
Canadian Cancer Trials Group
National Cancer Institute (NCI)
QuantumLeap Healthcare Collaborative
Mayo Clinic
Institut Curie
City of Hope Medical Center